Modelling seizure rates rather than time to an event within clinical trials of antiepileptic drugs

被引:1
|
作者
Bonnett, Laura J. [1 ]
Hutton, Jane L. [2 ]
Marson, Anthony G. [3 ,4 ,5 ]
机构
[1] Univ Liverpool, Dept Biostat, Waterhouse Bldg,Block F,1-5 Brownlow St, Liverpool L69 3GL, Merseyside, England
[2] Univ Warwick, Dept Stat, Coventry CV4 7AL, W Midlands, England
[3] Univ Liverpool, Univ Hosp Aintree, Ctr Clin Sci, Dept Mol & Clin Pharmacol, Liverpool L9 7LJ, Merseyside, England
[4] Walton Ctr NHS Fdn Trust, Lower Lane, Liverpool, Merseyside, England
[5] Liverpool Hlth Partners, Lower Lane, Liverpool, Merseyside, England
关键词
Cox model; PWP-TT; Negative binomial; Epilepsy; Seizures; FRACTIONAL POLYNOMIALS; TREATMENT FAILURE; EPILEPSY; REGRESSION; RISK; REMISSION; SANAD; LAMOTRIGINE; TOPIRAMATE;
D O I
10.1186/s12874-020-00965-5
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Predictive models within epilepsy are frequently developed via Cox's proportional hazards models. These models estimate risk of a specified event such as 12-month remission. They are relatively simple to produce, have familiar output, and are useful to answer questions about short-term prognosis. However, the Cox model only considers time to first event rather than all seizures after starting treatment for example. This makes assessing change in seizure rates over time difficult. Variants to the Cox model exist enabling recurrent events to be modelled. One such variant is the Prentice, Williams and Peterson - Total Time (PWP-TT) model. An alternative is the negative binomial model for event counts. This study aims to demonstrate the differences between the three approaches, and to consider the benefits of the PWP-TT approach for assessing change in seizure rates over time. Methods Time to 12-month remission and time to first seizure after randomisation were modelled using the Cox model. Risk of seizure recurrence was modelled using the PWP-TT model, including all seizures across the whole follow-up period. Seizure counts were modelled using negative binomial regression. Differences between the approaches were demonstrated using participants recruited to the UK-based multi-centre Standard versus New Antiepileptic Drug (SANAD) study. Results Results from the PWP-TT model were similar to those from the conventional Cox and negative binomial models. In general, the direction of effect was consistent although the variables included in the models and the significance of the predictors varied. The confidence intervals obtained via the PWP-TT model tended to be narrower due to the increase in statistical power of the model. Conclusions The Cox model is useful for determining the initial response to treatment and potentially informing when the next intervention may be required. The negative binomial model is useful for modelling event counts. The PWP-TT model extends the Cox model to all included events. This is useful in determining the longer-term effects of treatment policy. Such a model should be considered when designing future clinical trials in medical conditions typified by recurrent events to improve efficiency and statistical power as well as providing evidence regarding changes in event rates over time.
引用
收藏
页数:14
相关论文
共 27 条
  • [21] Bayesian design of multi-regional clinical trials with time-to-event endpoints
    Bean, Nathan William
    Ibrahim, Joseph George
    Psioda, Matthew Austin
    BIOMETRICS, 2023, 79 (04) : 3586 - 3598
  • [22] Novel application of a discrete time-to-event model for randomized oral immunotherapy clinical trials with repeat food challenges
    Purington, Natasha
    Andorf, Sandra
    Bunning, Bryan
    Chinthrajah, Sharon
    Nadeau, Kari
    Desai, Manisha
    STATISTICS IN MEDICINE, 2021, 40 (18) : 4136 - 4149
  • [23] Blinded continuous information monitoring of recurrent event endpoints with time trends in clinical trials
    Muetze, Tobias
    Salem, Susanna
    Benda, Norbert
    Schmidli, Heinz
    Friede, Tim
    STATISTICS IN MEDICINE, 2020, 39 (27) : 3968 - 3985
  • [24] Clinical phenotypes within non-surgical patients with mesial temporal lobe epilepsy caused by hippocampal sclerosis based on response to antiepileptic drugs
    Gomez-Ibanez, Asier
    Gasca-Salas, Carmen
    Urrestarazu, Elena
    Viteri, Cesar
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2013, 22 (01): : 20 - 23
  • [25] Biological drugs for systemic lupus erythematosus or active lupus nephritis and rates of infectious complications. Evidence from large clinical trials
    Steiger, Stefanie
    Ehreiser, Louisa
    Anders, Juliane
    Anders, Hans-Joachim
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [26] Bayesian adjusted R2 for the meta-analytic evaluation of surrogate time-to-event endpoints in clinical trials
    Renfro, Lindsay A.
    Shi, Qian
    Sargent, Daniel J.
    Carlin, Bradley P.
    STATISTICS IN MEDICINE, 2012, 31 (08) : 743 - 761
  • [27] Clinical efficacy and safety of the newer antiepileptic drugs as adjunctive treatment in adults with refractory partial-onset epilepsy: A meta-analysis of randomized placebo-controlled trials
    Gao, Lan
    Xia, Li
    Zhao, Fei-Li
    Li, Shu-Chuen
    EPILEPSY RESEARCH, 2013, 103 (01) : 31 - 44